Your browser doesn't support javascript.
loading
Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.
Marinescu, Daniel-Costin; Raghu, Ganesh; Remy-Jardin, Martine; Travis, William D; Adegunsoye, Ayodeji; Beasley, Mary Beth; Chung, Jonathan H; Churg, Andrew; Cottin, Vincent; Egashira, Ryoko; Fernández Pérez, Evans R; Inoue, Yoshikazu; Johannson, Kerri A; Kazerooni, Ella A; Khor, Yet H; Lynch, David A; Müller, Nestor L; Myers, Jeffrey L; Nicholson, Andrew G; Rajan, Sujeet; Saito-Koyama, Ryoko; Troy, Lauren; Walsh, Simon L F; Wells, Athol U; Wijsenbeek, Marlies S; Wright, Joanne L; Ryerson, Christopher J.
Afiliação
  • Marinescu DC; Department of Medicine, University of British Columbia, Vancouver, BC; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC. Electronic address: daniel.marinescu@vch.ca.
  • Raghu G; Center for Interstitial Lung Diseases, Department of Medicine, University of Washington, Seattle, WA.
  • Remy-Jardin M; Department of Thoracic Imaging, Institut Coeur Poumon, Boulevard Jules Leclercq, Lille, France.
  • Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Adegunsoye A; Section of Pulmonary and Critical Care, Department of Medicine, Chicago, IL.
  • Beasley MB; Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Chung JH; Department of Radiology, University of Chicago, Chicago, IL.
  • Churg A; Department of Pathology, Vancouver General Hospital, University of British Columbia, Vancouver, BC.
  • Cottin V; National Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, Hospices Civils de Lyon, Claude Bernard University Lyon, Lyon, France.
  • Egashira R; Department of Radiology, Faculty of Medicine, Saga University, Saga, Japan.
  • Fernández Pérez ER; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Denver, CO.
  • Inoue Y; Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.
  • Johannson KA; Department of Medicine, University of Calgary, Calgary, AB, Canada.
  • Kazerooni EA; Departments of Radiology & Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.
  • Khor YH; Respiratory Research@Alfred, Central Clinical School, Monash University, Melbourne, VIC; Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, VIC.
  • Lynch DA; Department of Radiology, National Jewish Health, Denver, CO.
  • Müller NL; Department of Radiology, University of British Columbia, Vancouver, BC.
  • Myers JL; Department of Pathology, University of Michigan, Ann Arbor, MI.
  • Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals, Guy's and St. Thomas' NHS Foundation Trust, London, England; National Heart and Lung Institute, Imperial College, London, England.
  • Rajan S; Department of Chest Medicine, Bombay Hospital Institute of Medical Sciences, Bhatia Hospital, Mumbai, India.
  • Saito-Koyama R; Department of Pathology, Tohoku University Graduate School of Medicine, Miyagi, Japan.
  • Troy L; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Walsh SLF; National Heart and Lung Institute, Imperial College, London, England.
  • Wells AU; Interstitial Lung Disease Unit, Royal Brompton Hospital, London, England.
  • Wijsenbeek MS; Center of Excellence for Interstitial Lung Diseases and Sarcoidosis, Department of Respiratory Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Wright JL; Department of Pathology, St. Paul's Hospital and University of British Columbia, Vancouver, BC.
  • Ryerson CJ; Department of Medicine, University of British Columbia, Vancouver, BC; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, BC.
Chest ; 162(3): 614-629, 2022 09.
Article em En | MEDLINE | ID: mdl-35738345
Recent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific guidelines were developed independently, without clear direction on how to apply their respective recommendations concurrently within a single patient, where discrimination between these two fibrotic interstitial lung diseases represents a frequent diagnostic challenge. The objective of this review, created by an international group of experts, was to suggest a pragmatic approach on how to apply existing guidelines to distinguish IPF and fHP. Key clinical, radiologic, and pathologic features described in previous guidelines are integrated in a set of diagnostic algorithms, which then are placed in the broader context of multidisciplinary discussion to guide the generation of a consensus diagnosis. Although these algorithms necessarily reflect some uncertainty wherever strong evidence is lacking, they provide insight into the current approach favored by experts in the field based on currently available knowledge. The authors further identify priorities for future research to clarify ongoing uncertainties in the diagnosis of fibrotic interstitial lung diseases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Fibrose Pulmonar Idiopática / Alveolite Alérgica Extrínseca Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Chest Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Pulmonares Intersticiais / Fibrose Pulmonar Idiopática / Alveolite Alérgica Extrínseca Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Qualitative_research Limite: Humans Idioma: En Revista: Chest Ano de publicação: 2022 Tipo de documento: Article